These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29475581)
1. Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's disease. Lu X; He SY; Li Q; Yang H; Jiang X; Lin H; Chen Y; Qu W; Feng F; Bian Y; Zhou Y; Sun H Bioorg Med Chem; 2018 May; 26(8):1665-1674. PubMed ID: 29475581 [TBL] [Abstract][Full Text] [Related]
2. Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies. Zhou Y; Lu X; Du C; Liu Y; Wang Y; Hong KH; Chen Y; Sun H Bioorg Med Chem Lett; 2021 Feb; 34():127756. PubMed ID: 33359445 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and activity of miconazole derivatives as dual BChE/IDO1 inhibitors for the treatment of Alzheimer's disease. Lu X; Liu Y; Qin N; Yang H; Qiao Y; Jiang X; Chen Y; Feng F; Liu W; Zhou Y; Sun H Future Med Chem; 2021 Jul; 13(13):1105-1125. PubMed ID: 33960203 [No Abstract] [Full Text] [Related]
4. Search for new multi-target compounds against Alzheimer's disease among histamine H Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease. Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease. Asadi M; Ebrahimi M; Mohammadi-Khanaposhtani M; Azizian H; Sepehri S; Nadri H; Biglar M; Amanlou M; Larijani B; Mirzazadeh R; Edraki N; Mahdavi M Chem Biodivers; 2019 Nov; 16(11):e1900370. PubMed ID: 31523926 [TBL] [Abstract][Full Text] [Related]
8. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors. Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562 [TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease. Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease. Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease. Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674 [TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents. Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343 [TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors. Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors. Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors. Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191 [TBL] [Abstract][Full Text] [Related]
17. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888 [TBL] [Abstract][Full Text] [Related]
18. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease. Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628 [TBL] [Abstract][Full Text] [Related]
19. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease. Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794 [TBL] [Abstract][Full Text] [Related]
20. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment. Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]